Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: J Rheumatol. 2013 Sep 15;40(11):10.3899/jrheum.130170. doi: 10.3899/jrheum.130170

Table 2.

Adverse events and SLE disease activity following Zostavax® vaccination

SLE Healthy
Herpes Zoster, n 0 0
Serious Adverse Event, n 0 0
ISR (any), n 3 3
 Erythema, tenderness, n 3 3
Vesicular lesions, n 0 0
2 week SLEDAI§ 0 (0–3) -
6 week SLEDAI§ 1 (0–3) -
12 week SLEDAI§ 0 (0–3) -
SLE flare, n 0 -
§

median (range)

ISR= injection site reaction

SLEDAI=Systemic Lupus Erythematosus Disease Activity Index